pancreatic adenocarcinoma resectable
Showing 1 - 7 of 7
Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel
Completed
- Pancreatic Cancer
- +4 more
- Ascorbic Acid
- +3 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 10, 2022
Pancreatic Adenocarcinoma Resectable Trial in Saskatoon (Irreversible Electroporation)
Withdrawn
- Pancreatic Adenocarcinoma Resectable
- Irreversible Electroporation
-
Saskatoon, Saskatchewan, CanadaUniversity of Saskatchewan
Apr 30, 2021
Pancreatic Adenocarcinoma Resectable, Pancreatic Adenocarcinoma Locally Advanced, Pancreatic Adenocarcinoma Metastatic Trial in
Completed
- Pancreatic Adenocarcinoma Resectable
- +2 more
-
Edegem, Antwerpen, Belgium
- +1 more
Sep 2, 2020
Metastatic Pancreatic Cancer, Pancreatic Cancer, Pancreas Cancer Trial in La Jolla (Ascorbic Acid, Paclitaxel protein-bound,
Withdrawn
- Metastatic Pancreatic Cancer
- +5 more
- Ascorbic Acid
- +3 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Jun 6, 2019
Metastatic Pancreatic Cancer, Pancreatic Cancer, Pancreas Cancer Trial in United States (Ascorbic Acid, Paclitaxel
Withdrawn
- Metastatic Pancreatic Cancer
- +5 more
- Ascorbic Acid
- +3 more
-
Scottsdale, Arizona
- +5 more
May 28, 2019
Pancreatic Adenocarcinoma Resectable, Neoadjuvant Chemo Trial in Hangzhou (AG regimen, mFolfirinox)
Recruiting
- Pancreatic Adenocarcinoma Resectable
- Neoadjuvant Chemotherapy
- AG regimen
- mFolfirinox
-
Hangzhou, Zhejiang, ChinaThe second affiliated hospital of Zhejiang University
Nov 20, 2018
Pancreatic Adenocarcinoma Resectable Trial in Edegem, Brussels (gemcitabine, Vismodegib, Neoadjuvant chemo)
Unknown status
- Pancreatic Adenocarcinoma Resectable
- gemcitabine
- +2 more
-
Edegem, Antwerpen, Belgium
- +1 more
Oct 22, 2012